Related Experiment Video
Updated: Oct 14, 2025

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Immunohematological and Clinical Characterization of Complement and Non-Complement Associated Warm Autoimmune
Sudipta Sekhar Das1, Anupam Chakrapani1, Soumya Bhattacharya1
1Department of Transfusion Medicine, Apollo Gleneagles Hospitals, Kolkata, 700054 India.
Complement-associated Warm Autoimmune Hemolytic Anemia (WAIHA) affects over a third of patients. Key risk factors include female gender, age over 40, and underlying etiology, aiding in better WAIHA management.
Area of Science:
- Hematology
- Immunology
- Clinical Medicine
Background:
- Warm autoimmune hemolytic anemia (WAIHA) involves antigen-antibody complexes activating complement.
- Complement-associated WAIHA (CWAIHA) and non-complement-associated WAIHA (NCWAIHA) may present differently.
- Understanding these differences is crucial for patient management.
Purpose of the Study:
- To investigate the clinical and immunohematological characteristics of CWAIHA versus NCWAIHA.
- To identify potential risk factors associated with CWAIHA.
- To inform diagnosis and treatment strategies for WAIHA.
Main Methods:
- Prospective study of 229 WAIHA patients.
- Comprehensive DAT evaluation for all participants.
- Analysis of patient data including hematological, biochemical, and clinical parameters.
Main Results:
- 36.2% of WAIHA patients had CWAIHA.
- Female gender, age >40, and secondary WAIHA were more common in CWAIHA.
- Strong DAT results (>2+) were observed in 86.7% of CWAIHA patients.
- Gender, age, etiology, and DAT IgG dilution were independent risk factors for CWAIHA.
Conclusions:
- Detailed characterization of CWAIHA and NCWAIHA is essential for evaluating disease, immunological behavior, prognosis, and treatment.
- Identifying CWAIHA risk factors improves WAIHA management by physicians and immunohematologists.
More Related Videos
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Complement System
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...